Objectives: The Gore (Flagstaff, Ariz) iliac branch endoprosthesis (IBE) has recently been United States (U.S.) Food and Drug Administration approved for treatment of common iliac artery (CIA) aneurysms. Despite excellent results in clinical trial, only four of 98 patients were treated for bilateral iliac aneurysms. The goal of this study was to examine real-world experience using the Gore IBE for bilateral CIA aneurysms.
Methods: A retrospective review of an international multicenter (16 U.S., 8 European) experience using the Gore IBE to treat bilateral CIA aneurysms was performed. Cases were limited to those occurring after Food and Drug Administration approval (February 2016) in the U.S. and after Conformité Européene mark (November 2013) in Europe. Patient demographics, presentation, anatomic characteristics, and procedural details were captured.
Results: Forty-seven patients (45 male, mean age 68 years, range 41-84 years) were treated with bilateral Gore IBE (27 U.S., 20 European). Six patients (12.7%) were symptomatic, and 12 patients (25.5%) were treated primarily for CIA aneurysm (aorta <5.0 cm). Mean CIA diameter was 40.3 mm. Three patients had aneurysmal internal iliac arteries (IIA). Two of these were sealed proximally at the IIA neck, and one required coil embolization of IIA branches to achieve seal in the largest first order branch. Technical success was achieved in 46 patients (97.9%). One IBE device was unable to be deployed due to severe IIA stenosis and required coil embolization of IIA branch and extension of limb to seal in external iliac artery (EIA). No type I or III endoleaks were noted. There was no significant perioperative morbidity or mortality. Operative details: anesthesia type (general,
, length of case (197.6 minutes; mean, 52-444 minutes), fluoroscopy time (50.1 minutes; mean, 25-107 minutes), contrast used (144 mL; mean, 44-350 mL). IIA branch adjunctive stenting was required in four patients (1 IIA distal dissection, 3 kinks). On follow-up imaging (mean, 6.5 months; range, 1-36 months), there were 12 type II endoleaks (25.5%) and no type I or III endoleaks. One of 80 IIA branches (1.2%) was occluded at 6 months and asymptomatic. Three patients occluded their EIA due to kinking or compression of the IBE, two underwent successful thrombectomy and stenting perioperatively, and one required femoral-femoral bypass at 6 months.
Conclusions: Preservation of bilateral IIA when repairing bilateral CIA aneurysms can be performed safely with excellent technical success and short-term patency rates using the Gore IBE device. Limb and branch occlusions are rare, usually occur due to kinking, and can be treated successfully with stenting most of the time. Objectives: This study examined the effect of operator specialty on 30-day stroke outcomes among patients undergoing carotid endarterectomy and carotid artery stenting.
Methods: We conducted a population-based, observational cohort study of all individuals who underwent carotid endarterectomy or stenting in Ontario, Canada (population, 13.6 million) between April 1, 2002, and March 1, 2015, using administrative claims databases. We stratified endarterectomy and stenting patients according to operator specialty and followed them for 30 days after the procedure. For carotid endarterectomy, we compared outcomes between vascular surgeons and nonvascular surgeons. For carotid artery stenting, we compared outcomes between radiologists and neurosurgeons. We built multilevel multivariable logistic regression models adjusted for patient demographics, comorbidities, carotid artery symptom status, and annual institutional and operator volume to examine rates of 30-day stroke and death; these models also accounted for within-operator clustering.
Results: A total of 16,544 patients were studied (n ¼ 14,301 endarterectomy and n ¼ 2,243 stenting). Vascular surgeons performed 55.7% of carotid endarterectomy procedures, followed by neurosurgeons (21.0%), general surgeons (15.3%), and cardiac surgeons (7.9%). Radiologists (82.5%) and neurosurgeons (17.5%) performed carotid artery stenting. In the endarterectomy group, the risk of stroke was higher among patients treated by nonvascular surgeons (3.6%) compared with vascular surgeons (2.5%; adjusted odds ratio [OR], 1.38; 95% confidence interval [CI], 1.11-1.71; P ¼ .004; Fig 1) . The risk of 30-day death was similar between the two groups (0.9% vs 0.8% for vascular surgery; adjusted OR, 1.19; 95% CI, 0.80-1.76; P ¼ .40). With respect to specific nonvascular surgery specialties, rates of 30-day stroke were higher in endarterectomy patients treated by neurosurgeons (3.8%; adjusted OR, 1.39; 95% CI, 1.09-1.78; P ¼ .009) and cardiac surgeons (4.2%; adjusted OR, 1.61; 95% CI, 1.07-2.45; P ¼ .025) compared with vascular surgeons (2.5%); general surgeons had a similar 30-day stroke rate to that of vascular surgeons (3.0% vs 2.5%, respectively; adjusted OR, 1.19; 95% CI, 0.84-1.70; P ¼ .33). Patients who underwent carotid artery stenting by radiologists vs neurosurgeons experienced stroke at similar rates (6.1% vs 5.9%, respectively; adjusted OR, 1.06; 95% CI, 0.59-1.90; P ¼ .86; Fig 2) .
Conclusions: The risk for periprocedural stroke was significantly higher among carotid endarterectomy patients treated by nonvascular surgeons 
4S

